Capforce Inc (CFOR) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Capforce Inc   (CFOR)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Capforce Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Capforce Inc 's ROA in the second quarter of 2026?
Capforce Inc achieved a return on average assets (ROA) of 140.44 % in its second quarter of 2026, this is above CFOR's average return on assets of -81.88%.
Capforce Inc assets over the 12 months ending in its second quarter of 2026 are valued at $44 million

ROA has improved compared to 91.51% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 4 other companies had a higher return on assets. While the total ranking for ROA unchanged, relative to the first quarter of 2026 at no. 43.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 576.73 % 302.77 % 290.92 % 136.93 % 381.42 %
Y / Y Net Income Change 1117.35 % - 375.24 % - -
Net Income (TTM) in million 62 23 23 7 16
Return On Assets (TTM) 140.44 % 91.51 % 128.39 % 61.52 % 167.89 %
CFOR's Total Ranking # 43 # 43 # 59 # 28 # 35
Total Assets (TTM) in million 89 37 38 13 13
Seq. Total Assets Change 137.3 % -1.58 % 201.09 % -3.76 % 41.23 %
Seq. Net Income Change - - - - -

CFOR's 5 Years Annual ROA >> Back to CFOR Management Effectiveness >> Compare CFOR ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 0
Sector # 5
Overall # 24

Return On Assets Statistics
High Average Low
214.54 %
-81.88 %
-346.65 %
(Dec 31 2024)   (Jun 30 2024)





Financial Statements
Capforce Inc 's Assets $ 89 million CFOR's Balance sheet
Capforce Inc 's Income $ 42 million Quarterly CFOR's Income Statement
CFOR's Income by Division See CFOR's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 290.92 % 417.19 % -92.63 % -64.34 % 47 %
Total Assets in million 38 10 2 26 72
Y / Y Net Income Change 106.75 % - - - -
Net Income in million 23 11 -33 -37 -35
Annual Return On Assets 61.7 % 116.65 % -1735.61 % -145.9 % -48.57 %

CFOR's 5 Years Annual ROA >> Back to CFOR Management Effectiveness >> Compare CFOR ROA to its Competitors



Comment on CFOR's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA deteriorated to 61.7 %, despite annual net income growth of 106.75 % to $23.48 million, from $11.36 million a year ago, as CFOR's assets increase to $38.06 million, by 106.75 %.


More Return On Assets Ratios
CFOR's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CFOR's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CFOR's Competitors
Subscribers only: Roa for Capforce Inc 's Suppliers
Subscribers only: Return On Assets for CFOR's Customers

You may also want to know
CFOR's Roi CFOR's Inventory Turnover Ratio CFOR's Growth Rates CFOR's Dividend Comparisons
CFOR's Profitability Ratios CFOR's Asset Turnover Ratio CFOR's Dividend Growth
CFOR's Roe CFOR's Valuation Ratios CFOR's Financial Strength Ratios CFOR's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Glucotrack Inc   151.40 %
Capforce Inc   141.40 %
Protagenic Therapeutics Inc new  137.58 %
Elutia Inc   108.72 %
Silexion Therapeutics Corp  99.09 %
Quince Therapeutics Inc   88.46 %
Interpace Biosciences Inc   85.91 %
Rigel Pharmaceuticals Inc  72.27 %
Traws Pharma inc   71.80 %
Actinium Pharmaceuticals Inc  71.73 %
Oramed Pharmaceuticals Inc  64.18 %
Atlantic Coastal Acquisition Corp Ii  54.09 %
Elite Pharmaceuticals Inc   46.11 %
Agenus Inc  44.86 %
Earth Science Tech Inc   44.02 %
Idexx Laboratories Inc  33.61 %

Date modified: 2026-08-20T07:46:22+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.